Display options
Share it on

Front Neurol. 2012 Oct 22;3:150. doi: 10.3389/fneur.2012.00150. eCollection 2012.

Antiphospholipid-related chorea.

Frontiers in neurology

Silvio Peluso, Antonella Antenora, Anna De Rosa, Alessandro Roca, Gennaro Maddaluno, Vincenzo Brescia Morra, Giuseppe De Michele

Affiliations

  1. Department of Neurological Sciences, Federico II University Naples, Italy.

PMID: 23097646 PMCID: PMC3477765 DOI: 10.3389/fneur.2012.00150

Abstract

Chorea is a movement disorder which may be associated with immunologic diseases, in particular in the presence of antiphospholipid antibodies (aPL). Choreic movements have been linked to the isolated presence of plasmatic aPL, or to primary, or secondary antiphospholipid syndrome. The highest incidence of aPL-related chorea is detected in children and females. The presentation of chorea is usually subacute and the course monophasic. Choreic movements can be focal, unilateral, or generalized. High plasmatic titers of aPL in a choreic patient can suggest the diagnosis of aPL-related chorea; neuroimaging investigation does not provide much additional diagnostic information. The most relevant target of aPL is β2-glycoprotein I, probably responsible for the thrombotic manifestations of antiphospholipid syndrome. Etiology of the movement disorder is not well understood but a neurotoxic effect of aPL has been hypothesized, leading to impaired basal ganglia cell function and development of neuroinflammation. Patients affected by aPL-related chorea have an increased risk of thrombosis and should receive antiplatelet or anticoagulant treatment.

Keywords: APS; Hughes’ syndrome; anti-β2-glycoprotein I antibodies; anticardiolipin antibodies; antiphospholipid antibody syndrome; antiphospholipid syndrome; chorea; lupus anticoagulant

References

  1. Lancet Neurol. 2009 Nov;8(11):998-1005 - PubMed
  2. Autoimmun Rev. 2006 Jan;5(1):70-5 - PubMed
  3. Semin Arthritis Rheum. 1987 May;16(4):253-9 - PubMed
  4. J Biol Chem. 1998 Oct 30;273(44):29272-7 - PubMed
  5. J Rheumatol. 2008 Nov;35(11):2165-70 - PubMed
  6. J Thromb Haemost. 2009 Nov;7(11):1767-73 - PubMed
  7. Hematol Oncol Clin North Am. 2008 Feb;22(1):53-65, vi - PubMed
  8. J Rheumatol. 1995 Aug;22(8):1589-92 - PubMed
  9. Lupus. 2012 Jun;21(7):734-5 - PubMed
  10. Best Pract Res Clin Rheumatol. 2008 Oct;22(5):847-61 - PubMed
  11. Autoimmun Rev. 2003 Oct;2(6):387-94 - PubMed
  12. Neurology. 2007 Aug 14;69(7):644-54 - PubMed
  13. Br J Haematol. 1990 Sep;76(1):101-7 - PubMed
  14. Medicine (Baltimore). 1993 Mar;72(2):113-24 - PubMed
  15. Mov Disord. 2007 Sep 15;22(12):1813-5 - PubMed
  16. Clin Rheumatol. 2007 Dec;26(12):2145-2147 - PubMed
  17. Rheumatology (Oxford). 2008 Nov;47(11):1628-34 - PubMed
  18. J Thromb Haemost. 2006 Feb;4(2):295-306 - PubMed
  19. Blood. 2003 Mar 1;101(5):1827-32 - PubMed
  20. J Thromb Haemost. 2011 Jul;9(7):1275-84 - PubMed
  21. Dev Med Child Neurol. 2011 Jun;53(6):522-8 - PubMed
  22. Medicine (Baltimore). 1997 May;76(3):203-12 - PubMed
  23. J Autoimmun. 1998 Oct;11(5):425-9 - PubMed
  24. Ann Rheum Dis. 2010 Dec;69(12):2074-82 - PubMed
  25. Arthritis Rheum. 1999 Apr;42(4):599-608 - PubMed
  26. Autoimmun Rev. 2009 May;8(6):500-5 - PubMed
  27. Thromb Res. 2002 Dec 15;108(5-6):263-71 - PubMed
  28. J Autoimmun. 2000 Sep;15(2):145-51 - PubMed
  29. Clin Rev Allergy Immunol. 2010 Apr;38(2-3):196-200 - PubMed
  30. Autoimmun Rev. 2006 Dec;6(2):76-80 - PubMed
  31. Lupus. 2003;12(12):908-15 - PubMed
  32. Mov Disord. 2011 Nov;26(13):2422-7 - PubMed
  33. Curr Rheumatol Rep. 2012 Feb;14(1):71-8 - PubMed
  34. Ann Rheum Dis. 2011 Jun;70(6):1083-6 - PubMed
  35. Lupus. 2009 Sep;18(10):889-93 - PubMed
  36. Arq Neuropsiquiatr. 2007 Jun;65(2B):433-9 - PubMed
  37. Clin Exp Dermatol. 1984 Nov;9(6):535-44 - PubMed
  38. Lupus. 2010 Apr;19(4):394-9 - PubMed
  39. Blood. 2009 Oct 1;114(14):3074-83 - PubMed
  40. Arthritis Rheum. 2002 Apr;46(4):1019-27 - PubMed
  41. Blood. 2005 Oct 1;106(7):2340-6 - PubMed
  42. Neurology. 1994 Nov;44(11):2197-9 - PubMed
  43. J Rheumatol. 1998 Jan;25(1):51-6 - PubMed
  44. J Clin Immunol. 2003 Sep;23(5):377-83 - PubMed
  45. J Clin Rheumatol. 2011 Mar;17(2):69-72 - PubMed
  46. Curr Neurol Neurosci Rep. 2011 Aug;11(4):385-95 - PubMed
  47. Mov Disord. 1999 May;14(3):530-2 - PubMed
  48. Exp Neurol. 2000 May;163(1):173-9 - PubMed
  49. J Thromb Haemost. 2011 Jul;9 Suppl 1:275-82 - PubMed
  50. Mov Disord. 2010 Aug 15;25(11):1538-49 - PubMed
  51. Hippokratia. 2010 Jul;14(3):215-6 - PubMed
  52. J Neurol Sci. 2008 Apr 15;267(1-2):166-9 - PubMed
  53. Am J Med. 1992 Aug;93(2):181-6 - PubMed
  54. Ann N Y Acad Sci. 2007 Jun;1108:540-53 - PubMed
  55. Semin Arthritis Rheum. 1992 Apr;21(5):275-86 - PubMed
  56. Am J Med. 1994 Jan;96(1):3-9 - PubMed
  57. Arthritis Rheum. 2005 May;52(5):1545-54 - PubMed
  58. Neurosci Lett. 1998 Nov 27;257(2):116-8 - PubMed
  59. Ann Intern Med. 1990 May 1;112(9):682-98 - PubMed
  60. Blood. 2011 Jan 27;117(4):1408-14 - PubMed
  61. Am J Med. 1996 Dec;101(6):576-83 - PubMed
  62. Stroke. 2000 Dec;31(12):3079-83 - PubMed
  63. Lancet. 1983 Nov 26;2(8361):1211-4 - PubMed
  64. Rev Med Interne. 1997;18(4):292-302 - PubMed
  65. Rev Med Interne. 2012 Apr;33(4):206-8 - PubMed
  66. Blood. 1995 Nov 15;86(10):3685-91 - PubMed
  67. Lupus. 1999;8(2):127-33 - PubMed
  68. Mov Disord. 2005 Jan;20(1):111-3 - PubMed
  69. Curr Rheumatol Rep. 2010 Feb;12(1):53-7 - PubMed
  70. Lupus. 2012 Jun;21(7):729-31 - PubMed
  71. Semin Thromb Hemost. 2008 Apr;34(3):236-50 - PubMed
  72. Autoimmun Rev. 2008 Feb;7(4):272-7 - PubMed
  73. Blood. 2007 Sep 1;110(5):1483-91 - PubMed
  74. Ann Rheum Dis. 2007 Oct;66(10):1327-33 - PubMed
  75. Blood. 2011 Jun 23;117(25):6939-47 - PubMed
  76. J Immunol. 2010 Jun 15;184(12):6622-8 - PubMed
  77. Rheumatol Int. 2011 Feb;31(2):197-200 - PubMed
  78. Thromb Haemost. 2010 Aug;104(2):335-41 - PubMed
  79. Autoimmun Rev. 2008 Jan;7(3):174-8 - PubMed
  80. Clin Exp Immunol. 1998 May;112(2):325-33 - PubMed
  81. Open Neurol J. 2008;2:32-4 - PubMed

Publication Types